BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38553526)

  • 21. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21.
    Liu W
    Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical implications of lncRNA LINC-PINT in cancer.
    Bukhari I; Khan MR; Li F; Swiatczak B; Thorne RF; Zheng P; Mi Y
    Front Mol Biosci; 2023; 10():1097694. PubMed ID: 37006616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA LINC-PINT retards the abnormal growth of airway smooth muscle cells via regulating the microRNA-26a-5p/PTEN axis in asthma.
    Gao P; Ding Y; Yin B; Gu H
    Int Immunopharmacol; 2021 Oct; 99():107997. PubMed ID: 34315115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Long Noncoding RNA Linc-Pint by Hepatitis C Virus in Infected Hepatocytes Enhances Lipogenesis.
    Khatun M; Sur S; Steele R; Ray R; Ray RB
    Hepatology; 2021 Jul; 74(1):41-54. PubMed ID: 33236406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LINC-PINT impedes DNA repair and enhances radiotherapeutic response by targeting DNA-PKcs in nasopharyngeal cancer.
    Wang YH; Guo Z; An L; Zhou Y; Xu H; Xiong J; Liu ZQ; Chen XP; Zhou HH; Li X; Liu T; Huang WH; Zhang W
    Cell Death Dis; 2021 May; 12(5):454. PubMed ID: 33963177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINC-PINT Suppresses the Aggressiveness of Thyroid Cancer by Downregulating miR-767-5p to Induce TET2 Expression.
    Jia M; Li Z; Pan M; Tao M; Wang J; Lu X
    Mol Ther Nucleic Acids; 2020 Dec; 22():319-328. PubMed ID: 33230437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA Linc-PINT inhibits miR-523-3p to hamper retinoblastoma progression by upregulating Dickkopf-1 (DKK1).
    Zhou X; Wang Y; Li Q; Ma D; Nie A; Shen X
    Biochem Biophys Res Commun; 2020 Sep; 530(1):47-53. PubMed ID: 32828314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.
    Yang X; Miao S; Mao X; Xiu C; Sun J; Pei R; Jia S
    Pathol Oncol Res; 2021; 27():584466. PubMed ID: 34257531
    [No Abstract]   [Full Text] [Related]  

  • 29. LINC-PINT Activates the Mitogen-Activated Protein Kinase Pathway to Promote Acute Myocardial Infarction by Regulating miR-208a-3p.
    Zhu J; Gu H; Lv X; Yuan C; Ni P; Liu F
    Circ J; 2018 Oct; 82(11):2783-2792. PubMed ID: 30249926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. lncRNA LINC-PINT is downregulated in melanoma and regulates cell proliferation by downregulating lncRNA BANCR.
    Huang Q; Zhang D; Diao Q; Lin M
    Oncol Lett; 2019 Sep; 18(3):2917-2922. PubMed ID: 31452772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishing a prognostic model based on five starvation-related long non-coding RNAs for clear cell renal cell carcinoma.
    Yu Z; Chen G; Feng Z; Li Y; Yu H; Shi W; Gou X; Zhang C; Peng X
    Aging (Albany NY); 2023 Jun; 15(14):6736-6748. PubMed ID: 37341994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long Non-coding RNA LINC-PINT Suppresses Cell Proliferation and Migration of Melanoma via Recruiting EZH2.
    Xu Y; Wang H; Li F; Heindl LM; He X; Yu J; Yang J; Ge S; Ruan J; Jia R; Fan X
    Front Cell Dev Biol; 2019; 7():350. PubMed ID: 31921860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p.
    Han X; Liu J; Liu Y; Mou L; Li C
    Cancer Manag Res; 2021; 13():4393-4401. PubMed ID: 34103994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review and meta-analysis of long noncoding RNA linc-UBC1 expression and prognosis and clinicopathological phenotypes in human cancers.
    Zhang X; Xie H; Luo M; Liang D; Lao W; Ma W; Lin Y
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):875-884. PubMed ID: 32460560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A lncRNA survey finds increases in neuroprotective LINC-PINT in Parkinson's disease substantia nigra.
    Simchovitz A; Hanan M; Yayon N; Lee S; Bennett ER; Greenberg DS; Kadener S; Soreq H
    Aging Cell; 2020 Mar; 19(3):e13115. PubMed ID: 32080970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linc-pint inhibits early stage pancreatic ductal adenocarcinoma growth through TGF-β pathway activation.
    Lu H; Yang D; Zhang L; Lu S; Ye J; Li M; Hu W
    Oncol Lett; 2019 May; 17(5):4633-4639. PubMed ID: 30944652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element.
    Marín-Béjar O; Mas AM; González J; Martinez D; Athie A; Morales X; Galduroz M; Raimondi I; Grossi E; Guo S; Rouzaut A; Ulitsky I; Huarte M
    Genome Biol; 2017 Oct; 18(1):202. PubMed ID: 29078818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TWIST1 methylation by SETD6 selectively antagonizes LINC-PINT expression in glioma.
    Admoni-Elisha L; Elbaz T; Chopra A; Shapira G; Bedford MT; Fry CJ; Shomron N; Biggar K; Feldman M; Levy D
    Nucleic Acids Res; 2022 Jul; 50(12):6903-6918. PubMed ID: 35694846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of long intergenic non-coding RNA, regulator of reprogramming, and its prognostic value in patients with glioblastoma.
    Toraih EA; El-Wazir A; Hussein MH; Khashana MS; Matter A; Fawzy MS; Hosny S
    Int J Biol Markers; 2019 Mar; 34(1):69-79. PubMed ID: 30852975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of LINC-PINT polymorphisms with lumbar disc herniation risk among Chinese Han population: a case control study.
    Wu Y; Bai M; Yu Y; Wang Y; Zhang Y
    J Orthop Surg Res; 2023 Aug; 18(1):585. PubMed ID: 37553573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.